TNFRSF1B and ovarian carcinoma: Also it should be mentioned that the ovarian cancer study used treatment-naive subjects just diagnosed with ovarian cancer, and this study used advanced SS subjects on a range of salvage therapies some of which might work to decrease in vivo Tregs cell numbers thus accounting for the more dramatic Tregs effect of TNFR2 antagonism.